Inari Medical to Present at the Canaccord Genuity 41st Annual Growth Conference

Rhea-AI Summary

Inari Medical, Inc. (NASDAQ: NARI), a medical device company specializing in venous diseases, announced its participation in the Canaccord Genuity 41st Annual Growth Conference. The presentation is scheduled for August 12, 2021, at 10:30 a.m. Eastern Time. Inari focuses on innovative catheter-based mechanical thrombectomy devices, such as the ClotTriever and FlowTriever systems, designed to treat deep vein thrombosis and pulmonary embolism effectively. Both devices have received FDA 510(k) clearance and CE Mark approval, emphasizing the company’s commitment to transforming patient care in venous thromboembolism.

IRVINE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that its management team will present at the Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12, 2021 at 10:30 a.m. Eastern Time.

About Inari Medical, Inc.
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.

Investor Contact:
Westwicke Partners
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

What is Inari Medical's stock symbol?

Inari Medical's stock symbol is NARI.

When will Inari Medical present at the Canaccord Genuity conference?

Inari Medical will present on August 12, 2021, at 10:30 a.m. Eastern Time.

What medical conditions do Inari Medical's products address?

Inari Medical's products address venous diseases, specifically deep vein thrombosis and pulmonary embolism.

What are the names of Inari Medical's thrombectomy devices?

Inari Medical's thrombectomy devices are named ClotTriever and FlowTriever.

Are Inari Medical's devices FDA approved?

Yes, both ClotTriever and FlowTriever have received FDA 510(k) clearance.

What is venous thromboembolism?

Venous thromboembolism (VTE) is a condition that includes deep vein thrombosis and pulmonary embolism.